ERS Studies Highlight Long-Term Effects of COVID-19
COVID-19 patients require supervised pulmonary rehabilitation to recover ERS researchers say.
Lockdowns: Should They Continue?
When lockdowns are done haphazardly, questions arise about whether they should continue.
How Has the COVID-19 Response Impacted People Living in Slum Neighborhoods?
Lockdowns implemented for pandemic control have broad health, social, and economic consequences. This is especially true for people who live and work in slum communities around the world.
Where Should We Target Limited Coronavirus Testing Resources?
University of Maryland professor of medical technology answers where limited testing resources ought to be directed given pandemic supply issues.
International Coronavirus 'Lockdown' Encroaches on Tuberculosis Epidemic Control
Though it may be associated with the past in popular culture, tuberculosis is still the world’s most fatal infectious disease, killing an estimated 1.5 million people each year.
Will COVID-19 Become a Seasonal Virus?
In a newly published paper, investigators believe the novel virus will follow similar patterns to seasonal viruses like influenza.
HPV Vaccination Does Not Increase Risk of Syndromes with Autonomic Dysfunction
A new Danish study found no evidence of a causal association between the quadrivalent human papillomavirus vaccination and syndromes with autonomic dysfunction.
National Academies Committee Considers Equitable Allocation of COVID-19 Vaccine
National Academies committee releases discussion draft on equitable allocation of vaccine against novel coronavirus for public comment.
Baricitinib Plus Remdesivir Improves Hospitalized COVID-19
New ACTT-2 findings show notable promise for a combination of the rheumatoid arthritis drug and the EUA-approved antiviral therapy.
CDC: Over 40% of Americans Missing Medical Care During COVID-19 Pandemic
Delayed or avoided medical care can increase death, severity of illness, and the chronic health impacts of acute illness.
Pfizer Phase 3 Coronavirus Vaccine Data Slated For October
Upping the phase 3 investigational vaccine trial size to 44,000 participants will also allow for the enrollment of new populations.
Speed and Accuracy of COVID-19 Testing
University of Maryland professor of medical technology explains the ways speed and accuracy are weighed when testing is deployed to detect COVID-19.
COVID-19 Side Effects: Ventilator Patients May Experience Permanent Nerve Damage
An examination of ventilator patients found a significant number of them could suffer from a variety of life-long injuries.
When Obesity-Driven Meta-Inflammation Meets SARS-CoV-2
COVID-19 is a threat to everyone without immunity, but obese patients fare worse on average.
Meta-Analysis Characterizes Complications of COVID-19 in Pregnancy
Review and meta-analysis identifies clinical manifestations, risk factors, and maternal and perinatal outcomes associated with COVID-19 in pregnancy.
Myocarditis Risk in COVID-Infected College Athletes
A discussion with an Ohio State investigator on early CMR findings among young athletes.
AstraZeneca, Oxford Resume COVID-19 Vaccine Trial After Safety Review
Investigators resumed phase 3 international assessments after independent committees and regulators deemed it safe to do so.
Medek Hand Sanitizer Recall: Methanol Contamination + Subpotent Ethanol Levels
In another of many hand sanitizer recalls since the start of the pandemic, FDA is working with Medek LLC to remove all lots of “M” hand sanitizer from store shelves.
Pharmaceutical Debrief: Merck PCV Phase 3 Data, Novavax COVID Results, Vaccine Trial Stoppage
A quick debrief of the week’s top FDA approvals, FDA authorizations, or other infectious disease pipeline developments from the past week.
Testing Reagents for SARS CoV 2: Institutional Stockpiling and Supply Chain Issues
Robert H. Christenson, PhD, University of Maryland, outlines the incentives for how SARS-CoV-2 testing reagents are acquired by institutions.
Professor of Medical Technology Provides COVID-19 Testing Breakdown
Robert H. Christenson, PhD, outlines the ways SARS-CoV-2 transmission is prevented during testing, how testing materials are acquired, and more.
Targeting the Innate Immune System to Neutralize the Cytokine Storm in Severe COVID-19
A clinical-stage immunology company has an investigational therapy looking to target the tumor necrosis factor cytokine.
Positive Phase 1 Results for the Novavax COVID-19 Vaccine
Results of the trial of Novavax’s NVX-CoV2373 vaccine have been published in the New England Journal of Medicine, showing the vaccine appeared safe and elicited strong immune responses.
Outbreaks of Measles Refute "Sustainability of Elimination"
Outbreaks in countries with high vaccine uptake prompted reassessment of the immunogenicity and persistence of trivalent measles, mumps and rubella vaccine
Does Political Instability Lower Trust in Vaccines?
A new study in The Lancet maps trends in vaccine confidence around the world.
New Treatment Guidelines for Antibiotic Resistant Infections | IDSA Update
New guidance from the Infectious Diseases Society of America offers timely practice advice for the clinical treatment of three of the most common drug-resistant pathogens.
Decision Diagnostics Grapples With FDA Emergency Use Authorization Process
Decision Diagnostics Corp. has submitted 2 applications with the FDA for a COVID-19 testing technology that the firm claims can identify the virus in about 10 seconds.
European Data Tracks Long-term Severe COVID-19 Pulmonary Effects
New research presented at ERS shows how critically ill COVID-19 patients face cardiac and pulmonary burdens weeks after recovery.
Merck Announces Results from 2 Phase 3 Studies on its Pneumococcal Conjugate Vaccine
The investigational vaccine was regarded as well-tolerated and elicited an immune response.
Clinic-Based Interventions Lead to Better Results in Youth with HIV
A new study that compared the results of a behavior intervention program for young adults living with HIV found outcomes were better when the intervention occurred in a clinic rather than at the patients’ homes.
